• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the editor.

作者信息

Netteland Dag Ferner, Næss Pål Aksel, Gaarder Christine, Helseth Eirik

机构信息

Department of Neurosurgery, Oslo University Hospital, Pb 4956, 0424, Nydalen, Oslo, Norway.

Faculty of Medicine, University of Oslo, Oslo, Norway.

出版信息

Scand J Trauma Resusc Emerg Med. 2024 Apr 15;32(1):28. doi: 10.1186/s13049-024-01199-w.

DOI:10.1186/s13049-024-01199-w
PMID:38622658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11020466/
Abstract
摘要

相似文献

1
Letter to the editor.致编辑的信。
Scand J Trauma Resusc Emerg Med. 2024 Apr 15;32(1):28. doi: 10.1186/s13049-024-01199-w.
2
An article on "letter to the editor".一篇关于“致编辑的信”的文章。
J Oral Maxillofac Pathol. 2023 Apr-Jun;27(2):254-256. doi: 10.4103/jomfp.jomfp_65_23. Epub 2023 Jul 13.
3
Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.作者对编辑来信的回复，编辑来信：作者对编辑来信的回复：日本人类乳头瘤病毒免疫接种的安全性问题：名古屋市不良事件监测数据的分析与评估
Jpn J Nurs Sci. 2020 Jan;17(1):e12310. doi: 10.1111/jjns.12310. Epub 2019 Dec 2.
4
How to write an editorial letter?如何撰写编辑信函？
Turk J Urol. 2013 Sep;39(Suppl 1):41-3. doi: 10.5152/tud.2013.053.
5
Letter to the Editor - The implications of the professionalization of health promotion in Canada: a response to JR Graham's letter to the editor.给编辑的信——加拿大健康促进专业化的影响：对 JR Graham 给编辑的信的回应。
Health Promot Chronic Dis Prev Can. 2017 May;37(5):172-173. doi: 10.24095/hpcdp.37.5.05.
6
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.信件1：对Sarkar博士等人致编辑的信的回复，信的主题为“谁说区分先兆子痫和新冠病毒感染很容易？”，涉及编号：S2210 - 7789(21)00539 - 0 信件2：对Hantoushzadeh博士等人致编辑的信的回复，信的主题为“新冠病毒疾病是先兆子痫的危险因素吗？这些患者是否应考虑使用阿司匹林预防先兆子痫？”，涉及编号：S2210 - 7789(21)00538 - 9
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
7
Letter to the Editor Regarding "Editor-in-Chief's April 2021 Letter on 'The Humility Button'".致编辑的信：关于“主编2021年4月关于‘谦逊按钮’的信”
World Neurosurg. 2022 May;161:209-210. doi: 10.1016/j.wneu.2022.02.127.
8
Reply to Letter to the Editor: Author Response to Letter to the Editor.致编辑信件的回复：作者对致编辑信件的回应。
J Am Acad Orthop Surg. 2023 Feb 1;31(3):e133-e134. doi: 10.5435/JAAOS-D-21-00805. Epub 2021 Sep 16.
9
Letter to the Editor Re: Author's Response to Letter to the Editor.致编辑的信：关于作者对致编辑信件的回复
Arch Phys Med Rehabil. 2020 Jun;101(6):1096-1097. doi: 10.1016/j.apmr.2019.12.022. Epub 2020 Mar 7.
10
A Letter to the Editor about Letter to the Editor.一封致编辑的关于致编辑的信。
J Indian Assoc Pediatr Surg. 2024 Mar-Apr;29(2):187. doi: 10.4103/jiaps.jiaps_5_24. Epub 2024 Mar 4.

本文引用的文献

1
Therapeutic efficacy of tranexamic acid on traumatic brain injury: a systematic review and meta-analysis.氨甲环酸治疗创伤性脑损伤的疗效：系统评价和荟萃分析。
Scand J Trauma Resusc Emerg Med. 2024 Mar 7;32(1):18. doi: 10.1186/s13049-024-01188-z.
2
Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials.氨甲环酸治疗急性创伤性脑损伤的疗效和安全性：系统评价和随机对照试验的荟萃分析。
Intensive Care Med. 2021 Jan;47(1):14-27. doi: 10.1007/s00134-020-06279-w. Epub 2020 Oct 20.
3
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.氨甲环酸对急性创伤性脑损伤患者死亡、残疾、血管阻塞事件和其他并发症的影响（CRASH-3）：一项随机、安慰剂对照试验。
Lancet. 2019 Nov 9;394(10210):1713-1723. doi: 10.1016/S0140-6736(19)32233-0. Epub 2019 Oct 14.